Cuu Long Pharmaceutical JSC
No trades
No trades
Compare with Cuu Long Pharmaceutical JSC
−50 VND
19.52 B VND
1.32 T VND
30.64 M
Company info
Sector
Industry
CEO
Minh Hoai Thi Vu
Website
Headquarters
Vinh Long
Founded
1976
IPO date
Sep 17, 2008
ISIN
VN000000DCL1
FIGI
BBG000CTDG48
Identifiers
ISIN VN000000DCL1
Cuu Long Pharmaceutical JSC engages in the manufacture, sale, import, and export of pharmaceutical, capsules, and medical instruments. Its other activities include the production for pharmaceutical packaging; cultivation and farming of medicinal materials; and distribution of cosmetics, nutritional food, and chemical. The company was founded in 1976 and is headquartered in Vinh Long, Vietnam.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of DCL is 38,600 VND — it has increased by 0.26% in the past 24 hours. Watch Cuu Long Pharmaceutical JSC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HOSE exchange Cuu Long Pharmaceutical JSC stocks are traded under the ticker DCL.
DCL stock has risen by 0.26% compared to the previous week, the month change is a −9.39% fall, over the last year Cuu Long Pharmaceutical JSC has showed a 81.22% increase.
DCL stock is 1.30% volatile and has beta coefficient of −0.25. Track Cuu Long Pharmaceutical JSC stock price on the chart and check out the list of the most volatile stocks — is Cuu Long Pharmaceutical JSC there?
Today Cuu Long Pharmaceutical JSC has the market capitalization of 2.82 T, it has decreased by −0.26% over the last week.
Yes, you can track Cuu Long Pharmaceutical JSC financials in yearly and quarterly reports right on TradingView.
DCL net income for the last quarter is 1.85 B VND, while the quarter before that showed −1.83 B VND of net income which accounts for 0.00% change. Track more Cuu Long Pharmaceutical JSC financial stats to get the full picture.
No, DCL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 5, 2026, the company has 878 employees. See our rating of the largest employees — is Cuu Long Pharmaceutical JSC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cuu Long Pharmaceutical JSC EBITDA is 90.04 B VND, and current EBITDA margin is 8.47%. See more stats in Cuu Long Pharmaceutical JSC financial statements.
Like other stocks, DCL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cuu Long Pharmaceutical JSC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cuu Long Pharmaceutical JSC technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cuu Long Pharmaceutical JSC stock shows the buy signal. See more of Cuu Long Pharmaceutical JSC technicals for a more comprehensive analysis.